{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:33:10Z","timestamp":1788049990091,"version":"build-2784847793"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.cyto.2021.155598","type":"journal-article","created":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T17:49:57Z","timestamp":1622915397000},"page":"155598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Dendritic cells and their associated pro-inflammatory cytokines augment to the inflammatory milieu in vitiligo skin"],"prefix":"10.1016","volume":"148","author":[{"given":"Ashu","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayasagar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Kurra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0403-5908","authenticated-orcid":false,"given":"Sudheer","family":"Arava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpana","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2021.155598_b0005","first-page":"1","article-title":"Evaluation of the effect of combined intralesional injection of prostaglandin F2\u03b1 with narrow band UVB phototherapy in treatment of resistant cases of vitiligo","author":"Eldelee","year":"2019","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.cyto.2021.155598_b0010","doi-asserted-by":"crossref","unstructured":"Ezzedine K, Eleftheriadou V, Whitton, van Geel N, Vitiligo. Lancet. 386(9988) (2015):74-84. doi:10.1016\/S0140-6736(14)60763-7.","DOI":"10.1016\/S0140-6736(14)60763-7"},{"issue":"3","key":"10.1016\/j.cyto.2021.155598_b0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/0378-6323.32708","article-title":"Vitiligo: compendium of clinico-epidemiological features","volume":"73","author":"Sehgal","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol."},{"issue":"4","key":"10.1016\/j.cyto.2021.155598_b0020","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2230.2004.01524.x","article-title":"Oxidant-antioxidant enzymes and lipid peroxidation in generalized vitiligo","volume":"29","author":"Koca","year":"2004","journal-title":"Clin Exp Dermatol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155598_b0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0625.2010.01181.x","article-title":"Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo","volume":"20","author":"Kemp","year":"2011","journal-title":"Exp Dermatol."},{"issue":"6","key":"10.1016\/j.cyto.2021.155598_b0030","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1365-2133.2006.07293.x","article-title":"Dopamine-induced apoptosis in human melanocytes involves generation of reactive oxygen species","volume":"154","author":"Chu","year":"2006","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.cyto.2021.155598_b0035","doi-asserted-by":"crossref","unstructured":"Spritz RA, The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma. Genome Med. (2010) 2(10):78. Published 2010 Oct 19. doi:10.1186\/gm199.","DOI":"10.1186\/gm199"},{"issue":"1","key":"10.1016\/j.cyto.2021.155598_b0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/0019-5154.92668","article-title":"Serum concentration of IL-6, IL-2, TNF-\u03b1, and IFN\u03b3 in Vitiligo patients","volume":"57","author":"Singh","year":"2012","journal-title":"Indian J Dermatol."},{"issue":"6","key":"10.1016\/j.cyto.2021.155598_b0045","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/1523-1747.ep12492607","article-title":"Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo","volume":"97","author":"Harning","year":"1991","journal-title":"J Invest Dermatol."},{"issue":"12","key":"10.1016\/j.cyto.2021.155598_b0050","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/nri1246","article-title":"Dendritic-cell control of pathogen-driven T-cell polarization","volume":"3","author":"Kapsenberg","year":"2013","journal-title":"Nat Rev Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155598_b0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: an update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology."},{"issue":"11","key":"10.1016\/j.cyto.2021.155598_b0060","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.4049\/jimmunol.0802008","article-title":"CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions","volume":"182","author":"Matsui","year":"2009","journal-title":"J Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2021.155598_b0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0952-7915(99)80026-0","article-title":"Peripheral T cell survival","volume":"11","author":"Freitas","year":"1999","journal-title":"Curr Opin Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2021.155598_b0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J Leukoc Biol."},{"issue":"3","key":"10.1016\/j.cyto.2021.155598_b0075","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3892\/etm.2016.2989","article-title":"CD80 and CD86 knockdown in dendritic cells regulates Th1\/Th2 cytokine production in asthmatic mice","volume":"11","author":"Li","year":"2016","journal-title":"Exp Ther Med."},{"issue":"9","key":"10.1016\/j.cyto.2021.155598_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045185","article-title":"CD80 and CD86 differentially regulate mechanical interactions of T-cells with antigen-presenting dendritic cells and B-cells","volume":"7","author":"Lim","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.cyto.2021.155598_b0085","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3389\/fimmu.2019.00772","article-title":"Innate Immune Cells' Contribution to Systemic Lupus Erythematosus","volume":"10","author":"Herrada","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.cyto.2021.155598_b0090","first-page":"10:1440","article-title":"Type1 Interferons Potential Initiating Factors Linking Skin Wounds With Psoriasis Pathogenesis","author":"Zhang","year":"2019","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155598_b0095","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.0105-2896.2009.00875.x","article-title":"Defining dendritic cells by conditional and constitutive cell ablation","volume":"234","author":"Bar-On","year":"2010","journal-title":"Immunol Rev."},{"issue":"1","key":"10.1016\/j.cyto.2021.155598_b0100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.0105-2896.2009.00886.x","article-title":"Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin","volume":"234","author":"Romani","year":"2010","journal-title":"Immunol Rev."},{"issue":"4","key":"10.1016\/j.cyto.2021.155598_b0105","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4049\/jimmunol.1901121","article-title":"Natural and Induced Tolerogenic Dendritic Cells","volume":"204","author":"Iberg","year":"2002","journal-title":"J Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2021.155598_b0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1532\/IJH97.04165","article-title":"Dendritic cells: sentinels of immunity and tolerance","volume":"81","author":"Kubach","year":"2005","journal-title":"Int J Hematol."},{"key":"10.1016\/j.cyto.2021.155598_b0115","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/857143","article-title":"The role of dendritic cells in tissue-specific autoimmunity","author":"Mbongue","year":"2014","journal-title":"J Immunol Res."},{"issue":"9","key":"10.1016\/j.cyto.2021.155598_b0120","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","article-title":"The Dual Nature of Type I and Type II Interferons","volume":"11","author":"Lee","year":"2018","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2021.155598_b0125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1600-0749.2007.00399.x","article-title":"Vitiligo puzzle: the pieces fall in place","volume":"20","author":"Westerhof","year":"2007","journal-title":"Pigment Cell Res."},{"key":"10.1016\/j.cyto.2021.155598_b0130","doi-asserted-by":"crossref","unstructured":"Satyam A, Tsokos MG, Tresback JS, Zeugolis DI, Tsokos GC. Cell derived extracellular matrix-rich biomimetic substrate supports podocyte proliferation, differentiation and maintenance of native phenotype. Adv Funct Mater. (2020) Oct 28;30(44):1908752. doi: 10.1002\/adfm.201908752. Epub 2020 Feb 19. PMID: 33692659; PMCID: PMC793906.","DOI":"10.1002\/adfm.201908752"},{"key":"10.1016\/j.cyto.2021.155598_b0135","doi-asserted-by":"crossref","unstructured":"Rashighi M, Agarwal P, Richmond JM, et al., CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. Sci Transl Med. (2014) 6(223):223ra23. doi:10.1126\/scitranslmed.3007811.","DOI":"10.1126\/scitranslmed.3007811"},{"issue":"3","key":"10.1016\/j.cyto.2021.155598_b0140","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaad.2011.07.018","article-title":"Circulatory levels of T-cell cytokines (interleukin [IL]-2, IL-4, IL-17, and transforming growth factor-\u03b2) in patients with vitiligo","volume":"66","author":"Khan","year":"2012","journal-title":"J Am Acad Dermatol."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2021.155598_b0145","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/08820139.2019.1688343","article-title":"Increases of CD80 and CD86 Expression on Peripheral Blood Cells and their Gene Polymorphisms in Autoimmune Thyroid Disease","volume":"49","author":"Watanabe","year":"2020","journal-title":"Immunol Invest."},{"issue":"1","key":"10.1016\/j.cyto.2021.155598_b0150","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","article-title":"Molecular mechanism and function of CD40\/CD40L engagement in the immune system","volume":"229","author":"Elgueta","year":"2009","journal-title":"Immunol Rev."},{"issue":"5","key":"10.1016\/j.cyto.2021.155598_b0155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nri3193","article-title":"Fine-tuning of dendritic cell biology by the TNF superfamily","volume":"12","author":"Summers deLuca","year":"2012","journal-title":"Nat Rev Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2021.155598_b0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.smim.2009.05.012","article-title":"CD40 and autoimmunity: the dark side of a great activator","volume":"21","author":"Peters","year":"2009","journal-title":"Semin Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2021.155598_b0165","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.4049\/jimmunol.1601988","article-title":"CD40L-Dependent Pathway Is Active at Various Stages of Rheumatoid Arthritis Disease Progression","volume":"198","author":"Guo","year":"2017","journal-title":"J Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2021.155598_b0170","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12026-020-09166-0","article-title":"Distorted frequency of dendritic cells and their associated stimulatory and inhibitory markers augment the pathogenesis of pemphigus vulgaris","volume":"68","author":"Das","year":"2020","journal-title":"Immunol Res."},{"issue":"4","key":"10.1016\/j.cyto.2021.155598_b0175","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1189\/jlb.1HI0714-351R","article-title":"Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells","volume":"97","author":"Bigley","year":"2015","journal-title":"J Leukoc Biol."},{"issue":"4","key":"10.1016\/j.cyto.2021.155598_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018907","article-title":"Th17 cells and activated dendritic cells are increased in vitiligo lesions","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621001812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621001812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:07:39Z","timestamp":1760908059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466621001812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":36,"alternative-id":["S1043466621001812"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155598","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dendritic cells and their associated pro-inflammatory cytokines augment to the inflammatory milieu in vitiligo skin","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155598"}}